Submission Details
| 510(k) Number | K112086 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 21, 2011 |
| Decision Date | October 14, 2011 |
| Days to Decision | 85 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K112086 is an FDA 510(k) clearance for the MEDRAD MARK 7 ARTERION (PEDESTAL SYSTEM / TABLE MOUNT SYSTEM), MEDRAD MARK 7 ARTERION SYRINGE, a Injector And Syringe, Angiographic (Class II — Special Controls, product code DXT), submitted by Medrad, Inc. (Indianola, US). The FDA issued a Cleared decision on October 14, 2011, 85 days after receiving the submission on July 21, 2011. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1650.
| 510(k) Number | K112086 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 21, 2011 |
| Decision Date | October 14, 2011 |
| Days to Decision | 85 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DXT — Injector And Syringe, Angiographic |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1650 |